West Pharmaceutical Services, Inc. (WST)

Market Cap	26.95B
Revenue (ttm)	2.93B
Net Income (ttm)	568.70M
Shares Out	73.21M
EPS (ttm)	7.58
PE Ratio	48.57
Forward PE	47.84
Dividend	$0.80 (0.22%)
Ex-Dividend Date	Jul 31, 2024

Volume	742,359
Open	384.48
Previous Close	385.73
Day's Range	364.89 - 385.87
52-Week Range	310.42 - 415.73
Beta	1.03
Analysts	Strong Buy
Price Target	435.20 (+18.2%)
Earnings Date	Apr 25, 2024

About WST

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhanc...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1923
• Employees: 10,600
• Stock Exchange: NYSE
• Ticker Symbol: WST

Financial Performance

In 2023, WST's revenue was $2.95 billion, an increase of 2.18% compared to the previous year's $2.89 billion. Earnings were $593.40 million, an increase of 1.28%.

Analyst Forecast

According to 5 analysts, the average rating for WST stock is "Strong Buy." The 12-month stock price forecast is $435.2, which is an increase of 18.20% from the latest price.

Price Target

$435.2

(18.20% upside)

Analyst Consensus: Strong Buy